Introduction {#s1}
============

Pluripotent stem cells closely resembling embryonic stem cells (ESCs) can be isolated from diploid parthenogenetic embryos generated by artificial activation of metaphase II (MII) arrested oocytes in which the genetic material in the second polar body is retained ([@DEQ144C22]; [@DEQ144C15]; [@DEQ144C7]). Recently, we reported the generation of several rhesus monkey parthenogenetic embryonic stem cells (PESCs) lines with stable, diploid female karyotypes that were morphologically indistinguishable from biparental, fertilized controls, expressed key pluripotency markers and demonstrated broad differentiation potential ([@DEQ144C7]).

Interestingly, we observed high levels of heterozygosity in all PESC lines at approximately 67% of gene loci that were polymorphic in the oocyte donors as a result of recombination during meiosis. Most PESCs were also heterozygous in the MHC region as they carried haplotypes identical to the egg donor females, indicating that they could provide histocompatible cells suitable for autologous transplantation. In the mouse, homozygous parthenogenetic embryos and PESCs can also be generated by artificial activation of MII oocytes under conditions that do not interfere with second polar body segregation ([@DEQ144C12]; [@DEQ144C20]). The resulting haploid genome is then experimentally diploidized by fusing 2-cell stage blastomeres. Here, we describe similar homozygous rhesus monkey PESCs derived from a spontaneously duplicated, haploid oocyte genome. Since the effect of homozygosity on PESCs pluripotency and differentiation potential is unknown, we assessed the similarities and differences in pluripotency markers and developmental potential by *in vitro* and *in vivo* differentiation in two genetically distinct PESC lines.

Although ESCs derived from fertilized embryos have been studied by global gene expression profiling, comparisons between biparental ESCs and PESCs have been limited to the analysis of marker expression and differentiation potential ([@DEQ144C15]; [@DEQ144C7]). Therefore, a major question still remained; are PESCs distinct or equivalent to ESCs in terms of global gene expression patterns? To address this question, we compared genome-wide expression profiles of monkey ESCs and PESCs. Furthermore, because the transcriptome of PESCs might be affected by genetic background, both heterozygous and homozygous cell lines were profiled.

In contrast to their fertilized counterparts, PESCs with both alleles of maternal origin should lack expression of paternally imprinted genes. Thus, we hypothesized that the transcriptional profiling of PESCs could aid in the identification of novel paternally expressed imprinted genes. Indeed, several known paternally expressed imprinted genes in humans ([@DEQ144C26]) were among the most down-regulated genes in PESCs when compared with biparental ESCs. We also selected 12 highly down-regulated putative-imprinted genes in PESCs and analyzed their imprinting status by allele-specific expression analysis. We identified one novel paternally imprinted gene, *INPP5F*, which was exclusively expressed from a paternal allele.

Conversely, PESCs with two sets of maternal chromosomes should display up-regulation of maternally imprinted genes due to biallelic expression. However, expression levels of known maternally expressed imprinted genes in PESCs were similar to control ESCs suggesting that parthenotes may not be suitable for screening of novel maternally imprinted genes.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

Adult rhesus females were used for oocyte collections. Throughout the study period the animals were maintained in facilities fully accredited by the American Association for the Accreditation of Laboratory Animal Care and all experimentation was conducted in accordance with the guidelines contained within the Guide for the Care and Use of Laboratory Animals, the ONPRC Institutional Animal Care and Use Committee, Office of Laboratory Animal Welfare, and USDA.

Parthenogenetic activation, fertilization by intracytoplasmic sperm injection and embryo culture {#s2b}
------------------------------------------------------------------------------------------------

Controlled ovarian stimulation and oocyte recovery has been described previously ([@DEQ144C7]). Oocytes, stripped of cumulus cells by mechanical pipetting after brief exposure (1 min) to hyaluronidase (0.5 mg/ml), were placed in chemically defined, protein-free hamster embryo culture medium (HECM)-9 medium at 37°C in 5% CO~2~, 5% O~2~ and 90% N~2~ until further use. Fertilization by intracytoplasmic sperm injection (ICSI) and embryo culture were performed as described ([@DEQ144C23]). Briefly, sperm were diluted with 10% polyvinylpyrrolidone (1:4; Irvine Scientific, Santa Ana, CA, <http://www.irvinesci.com>), and a 5-µl drop was placed in a micromanipulation chamber. A 30-μl drop of TH3 was placed in the same micromanipulation chamber next to the sperm droplet, and both were covered with paraffin oil. The micromanipulation chamber was mounted on an inverted microscope equipped with Hoffman optics and micromanipulators. An individual sperm was immobilized, aspirated into an ICSI pipette (Humagen, Charlottesville, VA, <http://www.humagenivf.com>) and injected into the cytoplasm of a metaphase II-arrested (MII) oocyte, away from the polar body. After ICSI, injected oocytes were placed in four-well dishes (Nalge Nunc International Co., Naperville, IL, <http://www.nalgenunc.com>) containing protein-free HECM-9 medium covered with paraffin oil and cultured at 37°C in 6% CO~2~, 5% O~2~ and 89% N~2~.

For parthenogenetic activation, unfertilized MII oocytes were exposed to 5 µM ionomycin (Calbiochem, San Diego, <http://www.emdbiosciences.com>) for 5 min followed by a 5-h incubation in 2 mM 6-dimethylaminopurine. Oocytes were then placed in four-well dishes (Nalge Nunc International, Naperville, IL, <http://www.nalgenunc.com>) containing HECM-9 medium and cultured at 37°C in 5% CO~2~, 5% O~2~ and 90% N~2~. Embryos at the 8-cell stage were transferred to fresh plates of HECM-9 medium supplemented with 5% fetal bovine serum (FBS) (HyClone, Logan, UT, <http://www.hyclone.com>) and cultured for a maximum of 9 days, with medium change every other day.

ESC and PESC derivation and culture {#s2c}
-----------------------------------

Zonae pellucidae of expanded blastocysts were removed with brief protease (0.5%) treatment, and inner cell masses (ICMs) were isolated using immunosurgery ([@DEQ144C23]). ICMs were plated onto Nunc four-well dishes containing mitotically inactivated mouse embryonic fibroblasts (mEFs) and ESC culture medium consisting of Dulbecco\'s modified Eagle\'s medium/Ham\'s F-12 medium (DMEM/F12; Invitrogen, Grand Island, NY) supplemented with 15% FBS (Hyclone, Logan, UT), 0.1 mM β-mercaptoethanol (Sigma, St. Louis, MO), 1% non-essential amino acids (Invitrogen) and 2 mM [l]{.smallcaps}-glutamine (Invitrogen). ICMs that attached to the feeder layer and initiated outgrowth were manually dissociated into small cell clumps with a microscalpel and replated onto new mEFs. After the first passage, colonies with ESC-like morphology were selected for further propagation, characterization and low-temperature storage. Medium was changed daily, and ESC colonies were split every 5--7 days by manual disaggregation and replating collected cells onto dishes with fresh feeder layers. Cultures were maintained at 37°C in 3% CO~2~, 5% O~2~ and 92% N~2~. Rhesus ESC lines ORMES-9 and ORMES-22 (Oregon Rhesus Macaque Embryonic Stem) and rPESC-2 (rhesus parthenogenetic embryonic stem cell) lines used in this study were produced in our laboratory and described earlier ([@DEQ144C23]; [@DEQ144C4]; [@DEQ144C7]).

Human ESC lines H1 and BG02 used in this study were cultured under the same conditions as rhesus ESCs, except that 20% Knock Out Serum Replacement (KSR; GIBCO) was used instead of FBS in the culture medium supplemented with 4 ng/ml FGF2 (Sigma).

*In vitro* and *in vivo* differentiation of ESCs and PESCs {#s2d}
----------------------------------------------------------

The differentiation methods were performed as previously described ([@DEQ144C3]; [@DEQ144C23]; [@DEQ144C30]). For embryoid body (EB) formation, entire colonies were loosely detached from feeder cells and transferred into feeder-free, six-well, ultra-low adhesion plates (Corning Costar, Acton, MA) and cultured in suspension in stem cell medium for 5--7 days. To induce cardiac differentiation, EBs were plated into collagen-coated six-well culture dishes (Becton Dickinson, Bedford, MA) to allow EB attachment and cultures were maintained in medium for 2--4 weeks. For teratoma production, 3--5 million undifferentiated cells from each cell line were harvested and injected into the hind leg muscle of 4-week old, SCID, beige male mice using an 18 g needle. Six to eight weeks after injection, mice were euthanized and teratoma tumors were dissected, sectioned and histologically characterized for the presence of representative tissues of all three germ layers.

Immunofluorescence procedures {#s2e}
-----------------------------

Immunofluorescence protocols have previously been described ([@DEQ144C3]; [@DEQ144C23]; [@DEQ144C30]). Undifferentiated and differentiated PESCs were fixed in 4% paraformaldehyde for 20 min and permeabilized with 0.2% Triton X-100 and 0.1% Tween-20. Non-specific reactions were blocked with 10% normal serum (Jackson ImmunoResearch). Cells were then incubated for 40 min with primary antibodies, washed three times and exposed to secondary antibodies conjugated with fluorochromes (Jackson ImmunoResearch) for 40 min. Next, cells were co-stained with 2 µg/ml 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) for 10 min, whole-mounted onto slides and examined under epifluorescence microscopy. Primary antibodies for OCT4, SSEA-4, TRA-1-60 and TRA-1-81 were from Santa Cruz Biotechnology.

Cytogenetic analysis {#s2f}
--------------------

Cytogenetic analysis was performed as previously described ([@DEQ144C3]). Briefly, mitotically active PESCs in log phase were incubated with 120 ng/ml ethidium bromide for 40 min at 37°C, 5% CO~2~, followed by 120 ng/ml colcemid (Invitrogen) treatment for 20--40 min. Cells were then dislodged with 0.25% trypsin, and centrifuged at 200 g for 8 min. The cell pellet was gently resuspended in 0.075 M KCl solution and incubated for 20 min at 37°C followed by fixation with methanol:glacial acetic acid (3:1) solution. Cytogenetic analysis was performed on metaphase cells from each ESC line following standard GTW-banding procedures. Images were acquired using the Cytovision Image Analysis System (Applied Imaging, Santa Clara, CA).

Microsatellite analysis {#s2g}
-----------------------

Microsatellite or short-tandem repeat (STR) genotyping was performed as previously described ([@DEQ144C30]). DNA was extracted from blood or cultured cells using commercial kits (Gentra, Minneapolis, MN). Six multiplexed PCR reactions were set up for the amplification of 44 markers representing 29 autosomal loci, 1 X-linked marker (DXS22 685) and 15 autosomal, MHC-linked loci. Based on the published rhesus monkey linkage map ([@DEQ144C28]), these markers are distributed in about 19 chromosomes. Two of the markers included in the panel, MFGT21 and MFGT22 ([@DEQ144C8]), were developed from *Macaca fuscata* and do not have a chromosome assignment. PCRs were set up in 25 µl reactions containing 30--60 ng DNA, 2.5 mM MgCl~2~, 200 µM dNTPs, 1X PCR buffer II, 0.5 U Amplitaq (Applied Biosystems) and fluorescence-labeled primers in concentrations ranging from 0.06 to 0.9 µM, as required for each multiplex PCR. Cycling conditions consisted of 4 cycles of 1 min at 94°C, 30 s at 58°C, 30 s at 72°C, followed by 25 cycles of 45 s at 94°C, 30 s at 58°C, 30 s at 72°C and a final extension at 72°C for 30 min. PCR products were separated by capillary electrophoresis on ABI 3730 DNA Analyzer (Applied Biosystems) according to the manufacturer\'s instructions. Fragment size analysis and genotyping was done with the computer software STR and (available at <http://www.vgl.ucdavis.edu/informatics/STRand/>). Primer sequences for MHC-linked STRs 9P06, 246K06, 162B17(A and B), 151L13, 268P23 and 222I18 were designed from the corresponding rhesus monkey BAC clone sequences deposited in GenBank (accession numbers AC148662, AC148696, AC148683, AC148682, AC148698 and AC148689, respectively). Loci identified by letter 'D' prefix were amplified using heterologous human primers.

Methylation analysis of imprinted genes {#s2h}
---------------------------------------

The methodology for methylation analysis has been previously described ([@DEQ144C24]; [@DEQ144C30]). Briefly, gDNA was subjected to bisulfite treatment using a CpG Genome Modification Kit (Chemicon International) according to the manufacturer\'s protocol. The sequence, annealing temperature and PCR cycle number of each primer pair were as previously reported ([@DEQ144C24]). PCR products were cloned and individual clones were then sequenced with an ABI 3100 capillary genetic analyzer (Applied Biosystems) using BigDye terminator sequencing chemistry ([@DEQ144C32]). Sequencing results were analyzed using Sequencher software (Gene Codes Corporation).

Qualitative and quantitative expression analysis {#s2i}
------------------------------------------------

Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer\'s instructions and further purified using RNeasy spin columns (QIAGEN, Chatsworth, CA). Final RNA concentrations and purity were determined by spectrophotometry. The integrity of RNA samples was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Total RNA was treated with DNase I before cDNA preparation using SuperScript III First-Strand Synthesis System for reverse transcription-polymerase chain reaction (RT--PCR) (Invitrogen) according to the manufacturer\'s instructions. The first-strand cDNA was further amplified by PCR using individual primer pairs for specific genes (Table SIII). All PCR samples were analyzed by electrophoresis and visualized on a transilluminator.

Quantitative real-time PCR (qPCR) analysis of all imprinted, *XIST* and telomere length genes has been previously described ([@DEQ144C5]; [@DEQ144C24]; [@DEQ144C30]). Information regarding sequences and annealing temperatures for each primer can be found in Table SIII. qPCR was performed on total RNA isolated from each PESC line, IVF-derived ORMES-22 and fibroblasts ([@DEQ144C23]). The cDNAs were synthesized from 800 ng of total RNA sample with SuperScript III reverse transcriptase (200 U/µl) (Invitrogen) using oligo(dT) primers. qPCR was performed on an ABI 7500 Fast Real-time PCR System with the SDS 1.4.0 program and using the ABI TaqMan Fast Universal PCR master mix (Applied Biosystems). To test for genomic DNA contamination, all qPCR reactions included a pilot '--RT' control with *GAPDH* probes and primer set. All reactions were analyzed in duplicates of three biological replicates. For each reaction, we included 5-fold dilutions of pooled cDNA to develop standard curves. The number of amplification cycles required for the fluorescence signal to reach a determined cycle threshold level (CT) was recorded for every sample and an internal standard curve. The RNA equivalent values for genes were calculated using the standard curve method followed by normalization with endogenous housekeeping *GAPDH* equivalent values derived from the same internal standard curve ([@DEQ144C3]). Relative telomere length was measured using primers Tel1 and Tel2 for telomeres and 36B4 for acidic ribosomal phosphoprotein P0 (RPLP0) used as a single-copy gene reference (Table SIII). To determine the CT value, two separate PCR runs were performed for each sample and primer pair. For each run a standard curve was generated using a reference genomic DNA isolated from IVF-derived ESC diluted to 0.06--40 ng per well (5-fold dilution). Calculation of the relative telomere/single-copy gene ratio (T/S value) and statistical analysis with SDS v. 1.1 software (Applied Biosystems) was used to determine the standard curve and CT values.

Microarray data analysis {#s2j}
------------------------

Microarray assays were performed at the OHSU Gene Microarray Shared Resource core. RNA samples were converted to labeled cRNA and hybridized to GeneChip Rhesus Macaque Genome Arrays (Affymetrix, Inc.). Gene-Chip operating system version 1.4 software (Affymetrix) was used to process images and generated probe level measurements (.cel files). Microarray data, including CEL and CHP files, can be accessed at the Gene Expression Omnibus (GEO) from <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=tjsddkusgemowbk&acc=GSE17964>. The information containing microarray analyses can be found in Data S1--S5. Processed image files were normalized across arrays using the robust multichip average algorithm ([@DEQ144C13]) and log transformed (base 2) to perform direct comparisons of probe set values between samples. GeneSifter (VizX Labs, Seattle, WA) microarray expression analysis software was used to identify differentially expressed transcripts. For a given comparison, one cell line was selected as the baseline reference, and transcripts that exhibited various fold change (ANOVA, *P* \< 0.05; Benjamini and Hochberg correction for false discovery rate) relative to the baseline were considered differentially expressed. To facilitate in-depth comparisons, processed image files were normalized with the robust multichip average algorithm and log transformed (base 2) using the StatView program. Corresponding microarray expression data were analyzed by pairwise differences determined with the student\'s *t*-test (*P* \< 0.05).

Allele-specific expression analysis {#s2k}
-----------------------------------

Characteristics of the single nucleotide polymorphisms (SNPs) employed for allele-specific expression analysis, PCR primers and conditions were previously described in detail ([@DEQ144C10]; [@DEQ144C11]). Expressed alleles were designed using Primer 3 software (<http://frodo.wi.mit.edu>) based on rhesus monkey consensus sequences obtained from GenBank. PCR products were treated with Exonuclease I/Shrimp alkaline phosphatase (ExoSAP-IT kit, USB) prior to sequencing. Sequencing results were analysed using Sequencher software (Gene Codes Corporation, Ann Arbor, MI). The relative positions of novel polymorphic sites for 12 genes are shown in Table IV. For characteristics of SNPs in human *INPP5F*, the following primers for PCR amplification were designed based on human consensus sequences obtained from GenBank: hINPP5F-F; 5′-CGGTCCCAGTCTCTTAGCAG-3′, and hINPP5F-R; 5′-CAACCTGGACCATGGAACTT-3′. Expressed alleles were determined with the same primers used in PCR amplification.

Statistical analysis {#s2l}
--------------------

Microarray analysis was statistically analyzed using ANOVA and the student\'s *t*-test. For quantitative analysis of maternally and paternally expressed imprinted genes, *Xist* expression, and telomere length measurements, statistical analysis with SDS v. 1.1 software (Applied Biosystems) was used.

Results {#s3}
=======

Genetic and epigenetic profiles of heterozygous and homozygous PESCs {#s3a}
--------------------------------------------------------------------

During routine genotyping of rhesus monkey ESC lines derived from *in vitro* fertilized (IVF) embryos (ORMES series, [@DEQ144C23]), we discovered that ORMES-9 displayed complete homozygosity across all analyzed loci. Initially, we employed a panel of 44 microsatellite markers for parentage analysis demonstrating that both the sperm and the egg donors for ORMES-9 carried 35 heterozygous loci (Table SI). Surprisingly, ORMES-9 was homozygous within all examined microsatellite loci that were all inherited from the egg donor with no contribution from the sperm, suggesting that this cell line resulted from a parthenogenetic embryo. To further corroborate this finding, we preformed an SNP analysis with a panel of 60 known SNPs localized to the 3′ ends of rhesus monkey genes ([@DEQ144C9]). Results confirmed homozygosity of ORMES-9 with only one allele inherited from the female (Table SII). This was an unusual finding since ORMES-9 originated from a blastocyst produced *in vitro* by ICSI. On other hand, conventional PESCs derived by the retention of the second polar body are highly heterozygous due to meiotic recombination ([@DEQ144C7]). ORMES-9 exhibited a normal diploid female karyotype with no detectable cytogenetic abnormalities.

In embryos and ESCs produced by fertilization, imprinted gene expression occurs exclusively or predominantly from one of the parental chromosomes. However, in parthenotes, expression of paternally imprinted genes that are normally silenced by passage through the female germline is not expected, since both alleles are of maternal origin. To further confirm the parthenogenetic nature of ORMES-9, we conducted expression analysis of several known maternally and paternally expressed imprinted genes. Expression levels of nine imprinted genes \[*H19*, *Ubiquitin protein ligase E3A* (*UBE3A*), *Pleckstrin homology-like domain family A member 2* (*PHLDA2*), *Cyclin-dependent kinase inhibitor 1C* (*CDKN1C*), *Tumor protein p 73* (*TP73*), *GNAS complex locus* (*GNAS*), *Homeobox protein DLX-5* (*DLX5*), *Probable phospholipid-transporting ATPase VA* (*ATP10A*) and *Solute carrier family 22 member 18* (*SLC22A18*)\] predominantly expressed from the maternal allele were similar to those of previously reported rhesus PESCs, rPESC-2 ([@DEQ144C7]) and IVF-derived ORMES-22 (Fig. [1](#DEQ144F1){ref-type="fig"}A). However, transcripts of paternally expressed *Necdin* (*NDN*), *Zinc-finger gene 2* (*ZIM2*), *Small nuclear ribonucleoprotein polypeptide N* (*SNRPN*), and *MAGE-like 2* (*MAGEL2*) were absent in both ORMES-9 and rPESC-2 but not in biparental ORMES-22 (Fig. [1](#DEQ144F1){ref-type="fig"}A). In addition, expression levels of *sarcoglycan, epsilon* (*SGCE*), *Paternally expressed 3* (*PEG3*), *Paternally expressed 10* (*PEG10*), and *Mesoderm-specific transcript homolog protein* (*MEST*) were significantly down-regulated in ORMES-9 and rPESC-2 when compared with biparental controls (Fig. [1](#DEQ144F1){ref-type="fig"}A). These results are broadly consistent with the conclusion that ORMES-9 originated from a parthenogenetic embryo. Interestingly, high levels of paternally imprinted *DIRAS family, GTP-binding RAS-like 3* (*DIRAS3*) and *insulin-like growth factor 2* (*IGF2*) were observed in both ORMES-9 and parthenogenetic rPESC-2 (Fig. [1](#DEQ144F1){ref-type="fig"}A). Figure 1Imprinted gene expression, X-inactivation and telomere length in PESCs. (**A**) Expression of known maternally (upper panel) and paternally (lower panel) expressed imprinted genes in ORMES-9 as assessed by quantitative (q)PCR. \*Expression levels of imprinted genes that were significantly down-regulated in PESCs when compared with biparental controls. (**B**) X-Inactivation status of primate PESCs determined by expression of *XIST*. The data represent average fold change relative to *GAPDH* from three biological replicates. (**C**) Measurement of relative telomere length in undifferentiated PESCs by qPCR analysis. The data represents the mean ± SEM (*n* = 4).

Imprinting is generally associated with regulatory regions or imprinting centers (ICs) that consist of differentially methylated domains. We performed methylation analysis of two previously described regions, namely, paternally methylated *IGF2/H19* and maternally methylated *SNURF/SNRPN* ICs in ORMES-9 using a bisulfite sequencing assay ([@DEQ144C7]). In the control biparental ORMES-22, both methylated and unmethylated alleles (clones) were detected within the *IGF2/H19* IC comprising 27 individual CpG sites ([Supplementary Data, Fig. S1](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)A). In contrast, no methylated clones were observed in ORMES-9 and rPESC-2 ([Supplementary Data, Fig. S1](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)A). Conversely, both ORMES-9 and rPESC-2 lines were heavily methylated within the *SNURF/SNRPN* IC, whereas ORMES-22 contained methylated and unmethylated clones ([Supplementary Data, Fig. S1](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)B). These data add another line of evidence supporting the monoparental origin of ORMES-9.

Expression of *X (inactive)-specific transcript* (*XIST*), a non-coding nuclear RNA, has been implicated in the process of X chromosome inactivation because of its localization within the inactivation center on the silenced X chromosome ([@DEQ144C2]). Thus, its expression is routinely used as an indicator of X-inactivation in female cells. Monkey female somatic cells as well as undifferentiated ESCs display strong *XIST* expression consistent with X-inactivation ([@DEQ144C30]). However, the status of X-inactivation in PESCs is unknown. To address this matter, we measured levels of *XIST* expression in parthenogenetic ORMES-9, rPESC-2 and IVF-derived female ORMES-22. Both ORMES-9 and rPESC-2 displayed high levels of *XIST* comparable to ORMES-22 suggesting that X-inactivation had occurred in parthenogenetic XX ESCs (Fig. [1](#DEQ144F1){ref-type="fig"}B). In contrast, *XIST* transcripts were low to undetectable in XY ESCs (Fig. [1](#DEQ144F1){ref-type="fig"}B).

Morphologically, ORMES-9 was indistinguishable from other ESCs derived from fertilized embryos and expressed markers of primate pluripotent stem cells including OCT4, stage-specific embryonic antigen (SSEA-4), tumor rejection antigen (TRA)-1-60 and TRA-1-81 ([Supplementary Data, Fig. S2](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)A). Induced *in vitro* differentiation resulted in various phenotypes including spontaneously contracting cell aggregates that expressed markers specific for cardiomyocytes and muscle tissue ([Supplementary Data, Fig. S2B](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)). When injected into immune-compromised mice, ORMES-9 gave rise to cell lineages representative of all three embryonic germ layers, further demonstrating its broad differentiation potential ([Supplementary Data, Fig. S2C](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)).

Telomeres are DNA--protein complexes at the ends of eukaryotic chromosomes that are progressively incised with each cell division in somatic cells leading to replicative senescence ([@DEQ144C21]). Maintenance of telomere length and unlimited proliferative potential in ESCs is sustained by ribonucleoprotein complex telomerase (*TERT*). To provide an additional pluripotency assay, we analyzed the relative telomere length in PESCs in comparison to somatic cells and ESCs derived from fertilized embryos. Both rPESC-2 and ORMES-9 displayed elongated telomere length comparable to IVF-derived ESCs while skin fibroblasts exhibited significantly shortened telomeres (Fig. [1](#DEQ144F1){ref-type="fig"}C).

Transcriptional profiling {#s3b}
-------------------------

To define the transcriptional signature of PESCs, we conducted microarray analysis of both ORMES-9 and rPESC-2 lines in comparison to IVF-derived ORMES-22 and adult monkey male skin fibroblasts using the Affymetrix Rhesus Macaque Genome array. Three types of comparisons were performed: (i) three biological replicates of each sample were compared against each other, (ii) each ESC line was compared against skin fibroblasts; and (iii) each PESC line was compared with each other and to IVF-derived ESCs. For each comparison, the detected signal for each probe set was plotted in a scatter graph and the correlation value was calculated. When the biological replicates of each cell type were compared, 99% transcriptional correlation was observed (Fig. [2](#DEQ144F2){ref-type="fig"}A and Data S1), suggesting that minimal technical variations were introduced during collection/preparation of RNA samples and subsequent hybridization. Comparison of PESCs to the fibroblasts resulted in a significantly lower transcriptional correlation (Fig. [2](#DEQ144F2){ref-type="fig"}B), however, high similarity was observed between PESCs and IVF-derived ESCs (Fig. [2](#DEQ144F2){ref-type="fig"}C). Figure 2Microarray expression analysis of PESCs. (**A**) Comparisons between biological replicates of the same cell line; (**B**) between PESCs or ESCs and fibroblasts; (**C**) between PESCs (rPESC-2 and ORMES-9) and IVF-derived ESCs (ORMES-22). X and Y axes indicate gene expression values for each compared cell line, *r* is correlation value with 95% confidence.

In ORMES-9 and rPESC-2 cell lines, 9722 probe sets were significantly up-regulated (\>3-fold difference; ANOVA, *P* \< 0.05) and 10 940 probe sets were down-regulated relative to skin fibroblasts. Analysis of up-regulated genes in parthenogenetic and control IVF-derived ESCs relative to fibroblasts revealed that 5167 probe sets overlapped. We selected 50 genes with the highest fold changes from this group. Several known pluripotency genes were on the top of this list including *POU class 5 homeobox 1* (*POU5F1*), *SRY (sex-determining region Y)-box 2* (*SOX2*), *Lin-28 homolog B* (*LIN28B*), *Nanog homeobox* (*NANOG*), *Claudin 6* (*CLDN6*), *Nuclear factor (erythroid-derived 2)-like 3* (*NFE2L3*), *Gamma-aminobutyric acid A receptor, beta 3* (*GABRB3*) and *Podocalyxin-like* (*PODXL*) (Table [I](#DEQ144TB1){ref-type="table"} in bold). These genes were highly expressed in both parthenote lines with comparable fold changes. Table IGenes with the greatest average fold change in monkey PESCs compared with skin fibroblasts.NumberAffymetrix probe set IDGene nameGene symbolGene expression fold change\*ORMES-22rPESC-2ORMES-91MmuSTS.2862.1.S1_atSecreted phosphoprotein 1*SPP1*395267307**2MmuSTS.2285.1.S1_atPOU class 5 homeobox 1*POU5F1*3022622653MmugDNA.27729.1.S1_atSRY (sex-determining region Y)-box 2*SOX2*283332272**4MmugDNA.15267.1.S1_atRNA-binding protein with multiple splicing 2*RBPMS2*2342082675MmugDNA.14543.1.S1_atLeucine rich repeat neuronal 1*LRRN1*185166178**6MmugDNA.33796.1.S1_s\_atLin-28 homolog B*LIN28B*1762101797MmugDNA.32128.1.S1_atNanog homeobox*NANOG*175153185**8MmugDNA.38382.1.S1_atHypothetical protein LOC696162*LOC696162*1732923689MmugDNA.35853.1.S1_atProminin 1*PROM1*173141169**10MmugDNA.34153.1.S1_atClaudin 6*CLDN6*171172224**11MmuSTS.3557.1.S1_atDNA (cytosine-5-)-methyltransferase 3 beta*DNMT3B*17020018812MmuSTS.3741.1.S1_atProtein tyrosine phosphatase, receptor-type, Z polypeptide 1*PTPRZ1*15522013513MmunewRS.875.1.S1_atNeuroligin 4, Y-linked*NLGN4Y*14217613414MmuSTS.1929.1.S1_atv-myc myelocytomatosis viral-related oncogene, neuroblastoma derived*MYCN*127109102**15MmugDNA.17159.1.S1_s\_atNuclear factor (erythroid-derived 2)-like 3*NFE2L3*12413819816MmuSTS.4813.1.S1_atGamma-aminobutyric acid A receptor, beta 3*GABRB3*11911582**17MmugDNA.20743.1.S1_atFraser syndrome 1*FRAS1*10914212918MmugDNA.33563.1.S1_atSimilar to histone cluster 3, H2a*LOC693768*10912110919MmuSTS.214.1.S1_atZic family member 3*ZIC3*1061388920MmugDNA.19659.1.S1_atInterleukin 17 receptor D*IL17RD*1058312721MmugDNA.15717.1.S1_atPutative neuronal cell adhesion molecule*PUNC*103737722MmuSTS.4486.1.S1_atSimilar to SRY (sex-determining region Y)-box 3*LOC696412*97515423MmuSTS.2870.1.S1_atEpithelial cell adhesion molecule*EPCAM*9615515624MmuSTS.4090.1.S1_atLeft-right determination factor 2*LEFTY2*965516525MmugDNA.42677.1.S1_atSimilar to developmental pluripotency associated 4*LOC706631*9511610926MmugDNA.17017.1.S1_atOrthodenticle homeobox 2*OTX2*9315812527MmugDNA.31410.1.S1_atHypothetical protein LOC722607*LOC722607*9210916328MmugDNA.35790.1.S1_atSolute carrier family 7 (cationic amino acid transporter, y+ system), member 3*SLC7A3*9013814429MmugDNA.12610.1.S1_atCD200 molecule*CD200*89899630MmugDNA.14842.1.S1_atCysteine-rich secretory protein LCCL domain containing 1*CRISPLD1*85606231MmuSTS.1323.1.S1_atSimilar to desmoplakin isoform II*LOC694860*78119140**32MmugDNA.33242.1.S1_atPodocalyxin-like*PODXL*7810999**33MmugDNA.30027.1.S1_atKIAA0746 protein*KIAA0746*77795334MmugDNA.10115.1.S1_atActivin A receptor, type IIB*ACVR2B*761028535MmugDNA.41979.1.S1_atSortilin-related receptor, L(DLR class) A repeats-containing*SORL1*75749036MmugDNA.21032.1.S1_atActin-binding LIM protein 1*ABLIM1*75707137MmugDNA.13233.1.S1_atBrain expressed X-linked 2*BEX2*71777938MmugDNA.14104.1.S1_atProtein phosphatase 1, regulatory (inhibitor) subunit 1A*PPP1R1A*67656639MmugDNA.42748.1.S1_atChromosome 9 open reading frame 58*C9ORF58*64856140MmuSTS.3925.1.S1_atSimilar to sal-like 2*LOC708367*59696941MmuSTS.1436.1.S1_atSimilar to proto-oncogene tyrosine-protein kinase LCK (p56-LCK) (Lymphocyte cell-specific protein-tyrosine kinase) (LSK) (T cell-specific protein-tyrosine kinase)*LOC717810*556411142MmugDNA.16646.1.S1_atPar-6 partitioning defective 6 homolog beta*PARD6B*52597043MmugDNA.29316.1.S1_atChromodomain helicase DNA binding protein 7*CHD7*51615844MmugDNA.36148.1.S1_atCytochrome P450, family 26, subfamily A, polypeptide 1*CYP26A1*50627545MmugDNA.21560.1.S1_s\_atCD24 molecule*CD24*49735646MmuSTS.3354.1.S1_atHypothetical protein LOC697860*LOC697860*49665547MmugDNA.31898.1.S1_s\_atApolipoprotein E*APOE*49557548MmugDNA.1925.1.S1_atSimilar to frizzled 5*LOC710796*48868349MmugDNA.14234.1.S1_atCyclin D2*CCND2*48525250MmugDNA.18039.1.S1_atDNA (cytosine-5-)-methyltransferase 3 alpha*DNMT3A*414143[^1]

As described above, in monoparental PESCs, a subset of imprinted genes normally expressed from the paternal allele are silenced or significantly down-regulated. Here, we used transcriptome analysis of PESCs to corroborate these observations. We also hypothesized that PESCs can be used to screen for novel paternally imprinted genes. Analysis of the microarray data identified 197 genes that were down-regulated (≤2-fold change, *P* \< 0.05) in both ORMES-9 and rPESC-2 lines when compared with biparental ORMES-22 (Data S2). Of these, 25 with the highest fold change were selected for further analysis (Table [II](#DEQ144TB2){ref-type="table"}). We randomly picked *Sorting nexin 5* (*SNX5*), *Forkhead box F2* (*FOXF2*), *Insulin-like growth factor binding protein 5 IGFBP5*) and *Homeobox D4* (*HOX4D*) from this group and validated their microarray expression levels by qPCR ([Supplementary Data, Fig. S3](http://humrep.oxfordjournals.org/cgi/content/full/deq144/DC1)). Interestingly, eight genes in this group were well-known paternally expressed imprinted genes \[*SNRPN*, *Pleiomorphic adenoma gene-like 1* (*PLAGL1*), *PEG3*, *NDN*, *PEG10*, *GNAS1 antisense* (*NESPAS*), *Nucleosome assembly protein 1-like 5* (*NAP1L5*) and *MAGEL2*\] (Table [II](#DEQ144TB2){ref-type="table"}, in bold). These results suggest that the transcriptional variation observed between parthenogenetic and biparental ESC samples is biological in origin. Comparisons of parthenogenetic cell lines to the biparental ESCs also identified 316 probe sets/genes that were significantly up-regulated (≥2-fold change, *P* \< 0.05) in both parthenotes (Data S3). A group of 25 genes from this category with the greatest fold change is presented in Table [III](#DEQ144TB3){ref-type="table"}. PESCs with two sets of maternal chromosomes might be expected to show up-regulation of maternally imprinted genes due to biallelic expression. However, in agreement with our qPCR data, no known maternally expressed imprinted genes were present in this group. Table IIHighly down-regulated genes in PESCs compared with ESC controls.NumberAffymetrix Probe Set IDGene nameGene symbolGene expression fold change\*rPESC-2 (heterozygous parthenote)ORMES-9 (homozygous parthenote)**1MmugDNA.26310.1.S1_atSmall nuclear ribonucleoprotein polypeptide N*SNRPN*161107**2Mmu.16433.2.S1_atCollagen, type III, alpha 1*COL3A1*2529**3MmuSTS.1142.1.S1_atSimilar to pleiomorphic adenoma gene-like 1 isoform 2*PLAGL1*17184MmugDNA.12446.1.S1_atPaternally expressed 3*PEG3*14155MmuSTS.1946.1.S1_atNecdin*NDN*14146MmugDNA.38558.1.S1_atPaternally expressed 10*PEG10*1313**7MmugDNA.36408.1.S1_atCarbonic anhydrase III, muscle specific*CA3*698MmuSTS.1960.1.S1_atForkhead box D1*FOXD1*889MmugDNA.23547.1.S1_atSorting nexin 5*SNX5*8710MmugDNA.21169.1.S1_atSimilar to chondroitin beta1,4 N-acetylgalactosaminyltransferase 2*LOC703703*7811MmugDNA.19752.1.S1_atForkhead box F2*FOXF2*8612MmugDNA.11688.1.S1_atChromosome 3 open reading frame 52*C3ORF52*55**13MmugDNA.1188.1.S1_atGNAS1 antisense*NESPAS*45**14MmugDNA.15601.1.S1_atMethyltransferase 10 domain containing*METT10D*4515MmugDNA.40734.1.S1_atActin, alpha, cardiac muscle 1*ACTC1*4516MmugDNA.3198.1.S1_atSerpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1*SERPINE1*4517MmugDNA.42888.1.S1_atInsulin-like growth factor binding protein 5*IGFBP5*44**18MmugDNA.35544.1.S1_atNucleosome assembly protein 1-like 5*NAP1L5*44**19MmugDNA.35385.1.S1_atHomeobox D4*HOXD4*4420MmugDNA.33494.1.S1_atSimilar to ELAV-like 2 isoform 3*LOC708195*5321MmugDNA.10922.1.S1_atInositol polyphosphate-5-phosphatase F*INPP5F*4422MmugDNA.31587.1.S1_atProtein tyrosine phosphatase, receptor type B*PTPRB*4423MmugDNA.29862.1.S1_atCentrosomal protein 68 kDa*CEP68*43**24MmuSTS.1453.1.S1_atMAGE-like 2*MAGEL2*33**25MmugDNA.17878.1.S1 atTransmembrane 4 L Six family member 19*TM4SF19*33[^2] Table IIIHighly up-regulated genes in rhesus PESCs compared with ESC controls.NumberAffymetrix Probe Set IDGene nameGene symbolGene expression fold change\*rPESC-2 (Heterozygous parthenote)ORMES-9 (Homozygous parthenote)1MmugDNA.36272.1.S1_atDCMP deaminase*DCTD*101782MmunewRS.938.1.S1_at2-deoxyribose-5-phosphate aldolase homolog*DERA*93883Mmu.12751.1.S1_atGrancalcin, EF-hand calcium binding protein*GCA*26314MmugDNA.31564.1.S1_atSH3 domain containing, Ysc84-like 1 (*S. cerevisiae*)*SH3YL1*27245MmugDNA.10404.1.S1_atSperm-associated antigen 16*SPAG16*13126MmugDNA.22282.1.S1_atWD repeat and FYVE domain containing 1*WDFY1*8147MmugDNA.3238.1.S1_s\_atMARVEL domain containing 3*MARVELD3*13138MmuSTS.857.1.S1_atSimilar to phosphatidylinositol N-acetylglucosaminyltransferase subunit P isoform 1*DSCRS*9109MmuSTS.1343.1.S1_atAdipose differentiation-related protein*ADFP*11810MmugDNA.34151.1.S1_atDynein, light chain, Tctex-type 3*DYNLT3*9711Mmu.11151.1.S1_s\_atSimilar to NADP-dependent leukotriene B4 12-hydroxydehydrogenase (15-oxoprostaglandin 13-reductase)*LTB4DH*7712MmugDNA.22506.1.S1_s\_atKynureninase (L-kynurenine hydrolase)*KYNU*7713MmugDNA.43436.1.S1_atMetallopeptidase with thrombospondin type 1 motif, 19*ADAMTS19*6614MmuSTS.3395.1.S1_atSimilar to T16G12.5*LOC704499*6715MmugDNA.30285.1.S1_atChromosome 1 open reading frame 115*C1ORF115*6616MmugDNA.22401.1.S1_atGoosecoid homeobox*GSC*6517MmugDNA.40626.1.S1_atLeucine-rich repeat-containing G protein-coupled receptor 5*LGR5*6418MmuSTS.2514.1.S1_atSimilar to hematopoietically expressed homeobox*LOC699012*5519MmugDNA.40512.1.S1_atChromosome 19 open reading frame 12*C19ORF12*4520MmugDNA.12480.1.S1_atTransmembrane protein 14A*TMEM14A*5421MmugDNA.32146.1.S1_atChromosome 7 open reading frame 46*C7ORF46*4522MmugDNA.12099.1.S1_atTransducer of ERBB2, 1TOB4523MmugDNA.15661.1.S1_atForkhead box A2*FOXA2*4424MmunewRS.87.1.S1_x\_atSimilar to zinc-finger protein 528*LOC720206*4425MmugDNA.42482.1.S1_atChromosome 14 open reading frame 135*C14ORF135*43[^3]

Finally, we compared expression profiles of rPESC-2 and ORMES-9 in an effort to define differences between heterozygous and homozygous parthenotes. In the ORMES-9 line, 4626 probe sets were significantly up-regulated (\>5-fold difference; *t*-test, *P* \< 0.05; Data S4) and 3762 probe sets were down-regulated (Data S5) relative to rPESC-2. The majority of the ontologically identified genes in this comparison are associated with cellular, metabolic, biological and developmental processes (Data S4, S5).

Allele-specific expression analysis of candidate imprinted genes {#s3c}
----------------------------------------------------------------

As indicated above, several known imprinted genes were among the top 25 down-regulated genes (Table [II](#DEQ144TB2){ref-type="table"}). We reasoned that the remaining genes in this group could represent novel paternally imprinted genes. To define the imprinted status of candidate genes, we initially screened a panel of IVF-derived biparental ESC lines (ORMES series, ([@DEQ144C23]; [@DEQ144C30]) and their respective parents for informative SNPs. We designed PCR primers within 3′UTR ends for 16 genes in this cohort based on the availability of rhesus monkey consensus sequences in GenBank. At least one informative SNP was identified for 12 of the 16 genes in several analyzed ORMES cell lines (Table [IV](#DEQ144TB4){ref-type="table"}). However, SNPs were not found for *Forkhead box F2* (*FOXF2*) and *similar to ELAV-like 2 isoform 3* (*LOC708195*) in any of the cell lines analyzed. Additionally, rhesus macaque sequences for *Chromosome 3 open reading frame 52* (*C3ORF52*) and *Methyltransferase 10 domain containing* (*METT10D*) were unavailable, and primers designed based on human sequences failed to amplify any PCR product. These outcomes precluded further allele-specific analysis of these four genes.

###### 

Summary of allele-specific expression analysis of highly down-regulated genes in PESCs.

  Gene          Genebank accession number   SNP and position   ORMES-1     ORMES-4     ORMES-5     ORMES-7     ORMES-21    ORMES-22    ORMES-23
  ------------- --------------------------- ------------------ ----------- ----------- ----------- ----------- ----------- ----------- -----------
  *INPP5F*      FJ932755                    C/T, 15            Paternal                Paternal                Paternal                
  *HOXD4*       FJ932754                    A/G 264            --          --          Paternal                --                      
                FJ932754                    C/G 298            --          Biallelic   Paternal                Biallelic               
  *ACTC1*       FJ997273                    G/C 162            --                      Paternal    --          --          --          --
                FJ997273                    A/G 182            --                      --          --          Biallelic   --          --
                FJ997273                    A/G 211            Biallelic               --          --          --          --          --
  *COL3A1*      FJ932748                    A/T 314                                                                        Biallelic   --
                FJ932748                    A/G 328                                                                        Biallelic   --
                FJ932748                    T/G 333                                                                        Biallelic   --
  *CA3*         FJ932749                    T/C 427                                                Biallelic               --          --
  *FOXD1*       FJ932750                    G/T 77                                                                         Maternal    Biallelic
  *SNX5*        FJ932751                    C/T 100                                                                        Biallelic   Biallelic
                FJ932751                    A/C 245                                                                        Biallelic   Biallelic
                FJ932751                    A/G 320                                                                        Biallelic   Biallelic
  *LOC703703*   FJ932752                    C/T 24                                     Biallelic                           Biallelic   --
                FJ932752                    A/G 461                                    --                                  Biallelic   --
  *SERPINE1*    FJ997274                    G/T 42                                     Biallelic   --                      --          --
                FJ997274                    C/T 172                                    Biallelic   --                      --          Biallelic
  *IGFBP5*      FJ932753                    G/T 39                                     --                                  Biallelic   --
                FJ932753                    T/C 59                                     --                                  Biallelic   --
                FJ932753                    T/G 222                                    Biallelic                           Biallelic   --
  *PTPRB*       FJ932756                    A/G 169                                    Biallelic                                       
  *CEP68*       FJ932757                    C/A 201                                    Biallelic                                       

ORMES-1 through -23---IVF-derived rhesus monkey ESC lines (ORMES series) ([@DEQ144C23]; [@DEQ144C30]). '-'No informative SNPs were found. The absence of results indicates that screening for presence of SNPs was not conducted. ORMES represent Oregon Rhesus Macaque Embryonic Stem. 'SNP and position' indicates the nucleotide polymorphism and position based on Genebank sequences.

Next, we sequenced cDNA samples in corresponding informative ESC lines. We determined that in all three ESC lines heterozygous for *INPP5F* (C/T), expression was monoallelic. Moreover, parental analysis of the males and females that contributed their alleles to these ESC lines demonstrated that the expressed allele was exclusively of paternal origin in all three cell lines (Table [IV](#DEQ144TB4){ref-type="table"} and Fig. [3](#DEQ144F3){ref-type="fig"}A). We further analyzed two human ESC lines, H1 and BG02 and determined that both were heterozygous for *INPP5F* (A/G) and expression of this gene in both human cell lines was also monoallelic (Fig. [3](#DEQ144F3){ref-type="fig"}B). Similarly, we determined that *Homeobox D4* (*HOXD4*) and *Actin, alpha, cardiac muscle 1* (*ACTC1*) were expressed from the paternal alleles in ORMES-5 (Fig. [3](#DEQ144F3){ref-type="fig"}A). However, in two other informative cell lines, expression of these genes was biallelic (Table [IV](#DEQ144TB4){ref-type="table"}). *ACTC1* was also biallelically expressed in informative human BG02 cells based on a G/A polymorphism located in exon 7 (data not shown). Parent-specific expression analysis of nine other genes in this group demonstrated that all were expressed from both alleles. Interestingly, expression of *Forkhead box D1* (*FOXD1*) was biallelic in ORMES-23 but monoallelically expressed from the maternal chromosome in ORMES-22. Figure 3Allele-specific expression analysis of candidate imprinted genes and transcriptional organization of the *INPP5F* locus. (**A**) Chromatograms demonstrating paternal expression of *INPP5F, ACTC1* and *HOXD4* in ORMES-5 cells. Polymorphic nucleotide positions in chromatograms are identified by arrows. For *INPP5F*, the paternal gDNA was C/T heterozygous while the maternal allele was T/T homozygous. Paternal, C allele was exclusively expressed as detected by cDNA sequencing. Similarly, G/C polymorphism was investigated for *ACTC1* showing that expressed G allele in ORMES-5 is of paternal origin. *HOXD4* expression was also monoallelic from the paternal allele based on two SNPs (A/G and C/G) in ORMES-5. (**B**) Chromatograms showing monoallelic expression of *INPP5F* in two human ESC lines H1 and BG02 based on a G/A polymorphism. (**C**) Schematic representation (not drawn to scale) of human *INPP5F* and *INPP5F_v2*. Horizontal bars indicate amplified regions to differentiate expression of *INPP5F* and *INPP5F_v2*. '\*'The position of a G/A polymorphism. (**D**) Expression of *INPP5F* and *INPP5F_v2* transcripts in monkey ORMES cell lines and (**E**) human ESC lines assessed by RT--PCR. The expected size of PCR products for *INPP5F* and *INPP5F_v2* was 466 bp and 299 bp, respectively. 'Y', 'S' and 'R' in the sequences labeling at the top of the chromatograms represent C/T, G/C and A/G polymorphisms, respectively.

Discussion {#s4}
==========

Therapeutic potential and controversies surrounding ESCs as well as experimentally induced pluripotent stem cells derived by reprogramming of somatic cells using somatic cell nuclear transfer or iPS approaches have been widely discussed. However, a third alternative approach---parthenogenesis---has been considered as suboptimal and sidelined from the stem cell debate. PESCs are unique because their derivation does not involve destruction of viable embryos or genetic transformation using transgenes. Therefore, interest in PESCs has mainly centered on their potential role in cell replacement therapies and their advantages over other alternative pluripotent stem cells including: (i) high efficiency of derivation, similar to their IVF counterparts; (ii) source of histocompatible cells (in terms of both nuclear and mitochondrial genomes) for autologous transplantation to egg donors; and (iii) preclusion of most ethical issues associated with the destruction of potentially viable embryos. However, concerns remain whether or not differentiation and engraftment of PESCs is robust considering the potentially disrupted expression of many paternally imprinted genes. Also, it has yet to be determined whether homozygosity in parthenotes within critical genomic regions compared with IVF-derived cells might affect cell function. Loss of heterozygosity may influence cell survival and differentiation. For example, cells may express multiple genetic defects because all of the recessive mutant alleles on the affected chromosome are unmasked. However, based on our previous observations in the rhesus monkey and published reports in mouse and human PESCs ([@DEQ144C15]; [@DEQ144C16]; [@DEQ144C27]; [@DEQ144C7]), the majority of loci in parthenotes are heterozygous, having undergone meiotic recombination prior to derivation. Such phenomenon may have influenced their high differentiation potential, which is indistinguishable from biparental controls. The discovery of a highly homozygous parthenote cell line presented a unique opportunity to study the effect of zygosity status on differentiation potential and imprinted gene expression in primate PESCs. Since conventional parthenotes created by retention of the second polar body display a significant degree of heterozygosity ([@DEQ144C7]), the homozygosity observed in ORMES-9 suggests that diploidization has occurred after completion of meiosis, possibly during the first mitotic division. An explanation for the mechanism responsible for restoration of a diploid state for this phenomenon is currently unavailable. We recently discovered another homozygous ESC line produced from a fertilized embryo suggesting that spontaneous parthenogenesis following ICSI is not a rare event (unpublished data). Moreover, description of a homozygous parthenote ESC line derived from a human zygote displaying a single pronucleus following conventional IVF supports the notion that ICSI or conventional IVF procedures can induce parthenogenetic oocyte activation without a paternal genetic contribution from the sperm ([@DEQ144C18]).

We found that, similar to rPESC-2, expression of most paternally imprinted genes was down-regulated or absent in the homozygous ORMES-9 cell line. Methylation analysis also demonstrated the lack of paternal imprints in these cells. These results are broadly consistent with the conclusion that ORMES-9 is of parthenogenetic origin. We show here that homozygous parthenote ESCs are similar to previously described parthenote cells and biparental ESCs derived from sperm-fertilized embryos with respect to expression of common pluripotency markers, self-renewal and the capacity to generate cell derivatives representative of all three germ layers *in vivo* and *in vitro* ([@DEQ144C23]; [@DEQ144C7]). Hence, it is reasonable to speculate that loss of heterozygosity does not interfere with PESC pluripotency. However, whether this proves to be the case for all parthenote-derived cells could well depend upon the presence of mutations within homozygous genes in specific cell lines. Further evaluations of *in vitro* and *in vivo* differentiation ability of PESCs compared with ESCs must be carried out to fully assess the phenomenon of homozygosity.

Expression profiling revealed that primate PESCs are, in general, transcriptionally similar to ESCs derived from fertilized embryos but divergent from somatic cells. Both strongly express genes implicated in the maintenance of pluripotency, self-renewal, genome surveillance, and cell fate determination in pluripotent stem cells ([@DEQ144C31]; [@DEQ144C1]; [@DEQ144C3]). However, we show significant differences between the transcriptomes of IVF-derived ESCs and parthenotes. The availability of this global transcriptional signature provides a database that will be an important reference for preclinical testing of PESCs in non-human primates. Perhaps, interpretation of differentially expressed genes in parthenotes will provide insights into the role of such differences in cell differentiation. Recent evidence suggests that, due to the striking similarities between pluripotent stem cells, distinguishing PESCs from those derived from fertilized or cloned embryos will require unequivocal demonstration of genetic homozygosity in selected regions using sensitive genome-wide fingerprinting analyses ([@DEQ144C16]). Several differentially expressed genes between parthenote and biparental cell lines identified in this study may potentially serve as markers of parthenogenetic cells.

As predicted, a list of down-regulated genes in parthenotes includes many known imprinted genes that are normally expressed from the paternal allele. Thus, expression profiling could serve as a sensitive assay to validate known imprinted genes in ESCs and to discover novel paternally imprinted genes. Identification of novel imprinted genes is particularly challenging because monoallelic expression may occur only in one of several possible isoforms, only in particular tissues, or only during particular stages of development. In addition, imprinting of some genes is not absolute, i.e. predominant expression from one of the parental alleles and lower expression levels from the other. Several approaches have been developed to predict or to discover imprinted genes in various tissues including computational methods and expression profiling of tissues carrying uniparental disomies ([@DEQ144C29]; [@DEQ144C19]). Novel imprinted genes have also been identified by assaying monoparental parthenogenetic or androgenetic mouse fetuses ([@DEQ144C17]; [@DEQ144C25]). Here we analyzed the imprinting status of 12 significantly down-regulated candidate genes in primate parthenotes. All but three were expressed biallelically in biparental ESCs suggesting that these genes are not imprinted or have undergone imprint loss. Allele-specific expression analysis demonstrated strictly paternal expression of *INPP5F*, an inositol phosphatase gene, in rhesus monkey IVF-derived ESCs. Previous studies indicated that mouse and human *INPP5F_v2*, a splicing variant of *INPP5F*, is imprinted in the brain and fetal spinal cord tissue but biallelically expressed in other tissues ([@DEQ144C6]; [@DEQ144C33]). *INPP5F_v2* uses an alternative transcriptional start site within intron 15 of parental *INPP5F* and thus has a unique alternative first exon, but shares four exons and part of the last exon with *INPP5F*. Using primers specific to *INPP5F* and *INPP5F_v2*, we demonstrated that both genes are expressed in monkey and human ESCs. Allele-specific analysis based on the SNP located within the shared untranslated region in the last exon between *INPP5F* and *INPP5F_v2* 3′UTR end showed that expressed transcripts were exclusively of paternal origin. Similar analysis of two human ESC lines confirmed that *INPP5F* is also monoallelically expressed in these cells. Studies using knockout mice suggested that *Inpp5f* is a functionally important modulator of cardiomyocyte size and cardiac response to stress ([@DEQ144C34]). However, until now the imprinting status of *INPP5F* remained unknown.

Two other candidate imprinted genes, *HOXD4* and *ACTC1*, were also monoallelically expressed from the paternal allele in one particular cell line, ORMES-5, while expression was biallelic in two other ESC lines. We previously reported dysregulation of imprinted *H19* and *IGF2* leading to biallelic expression in monkey ESC lines ([@DEQ144C11]). Interestingly, ORMES-5 was the only cell line that showed normal maintenance of imprinting and maternal expression of *H19*. Thus, it is possible that *HOXD4* and *ACTC1* represent imprinted genes that are susceptible to environmental stress during *in vitro* culture resulting in loss of imprinting in some ESC lines.

Overall, we define here the transcriptional signature of primate PESCs and similarities and differences in comparison to IVF-produced ESCs, which will provide valuable information for future experiments related to PESCs development and identification. Furthermore, by using allele-specific expression analysis of a panel of down-regulated genes in PESCs, we identified a novel imprinted gene. Additional imprinted genes may be identified using this gene expression database and subsequent procedures.
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[^1]: Bold fonts represent known pluripotency genes. \*The fold change was calculated for each stem cell line versus the level of expression for a particular gene in adult monkey skin fibroblasts. ORMES-9 and ORMES-22 represent Oregon Rhesus Macaque Embryonic Stem-9 and -22, respectively, and rPESC-2 represent rhesus parthenogenetic embryonic stem cell.

[^2]: Bold fonts are known paternally expressed imprinted genes. \*The fold change (decrease) was calculated for PESCs versus the level of expression for a particular gene in the conventionally derived ORMES-22. ORMES-9 and ORMES-22 represent Oregon Rhesus Macaque Embryonic Stem-9 and -22, respectively and rPESC-2 represent rhesus parthenogenetic embryonic stem cell.

[^3]: \*The fold change was calculated for PESCs versus the level of expression in the conventionally derived ORMES-22 line. ORMES-9 and ORMES-22 represent Oregon Rhesus Macaque Embryonic Stem-9 and -22, respectively and rPESC-2 represent rhesus parthenogenetic embryonic stem cell.
